Nonclinical precedent Request an invite
Species
Mouse and cynomolgus monkey (general tox); mouse and rabbit (EFD)
“The mouse and monkey were used for the single- and repeat-dose toxicity studies, and mouse and rabbit were used for the EFD toxicity studies.”
✓ VerifiedFDA multi-discipline review, p. 56Source ↗
Why that species
Sequence homology to hTR template region; 100% complementary in monkey, 9/13 mouse, 11/13 rat/rabbit
“These species were selected based on sequence homology to the template region of the RNA component of human telomerase and expected relevant pharmacologic action of imetelstat across species, from human to monkey to rabbit to rodent, as well as species-specific sensitivities to known ODN class effects.”
✓ VerifiedFDA multi-discipline review, p. 56Source ↗
Surrogate molecule
No surrogate; clinical molecule tested in mouse, monkey and rabbit despite rodent mismatches
“Despite the mismatches, IC50 values are similar in tumour cell lines from all tested species, supporting their relevance for toxicology studies.”
✓ VerifiedEMA assessment report, p. 36Source ↗
Species: general tox
Mouse and monkey
“The mouse and monkey were used for the single- and repeat-dose toxicity studies, and mouse and rabbit were used for the EFD toxicity studies.”
✓ VerifiedFDA multi-discipline review, p. 56Source ↗
Species: DART
Mouse and rabbit (EFD)
“The mouse and monkey were used for the single- and repeat-dose toxicity studies, and mouse and rabbit were used for the EFD toxicity studies.”
✓ VerifiedFDA multi-discipline review, p. 56Source ↗
Species: carcinogenicity
Not conducted; mouse and rat carcinogenicity studies required as PMRs
“To address the carcinogenicity risk assessment of imetelstat, there will be separate Post Marketing Requirements (PMRs) for carcinogenicity assessments in the mouse and rat species.”
✓ VerifiedFDA multi-discipline review, p. 43Source ↗
Surrogate used in
No surrogate used; clinical molecule active across tested species
“Despite the mismatches, IC50 values are similar in tumour cell lines from all tested species, supporting their relevance for toxicology studies.”
✓ VerifiedEMA assessment report, p. 36Source ↗

Same question, other oligonucleotides

Amondys 45

casimersen · DMD exon 45 (PMO)
Adult male mouse and cynomolgus monkey; juvenile male rat

Amvuttra

vutrisiran · TTR (siRNA)
Rat and cynomolgus monkey (monkey only pharmacologically active; rat for off-target/class tox); rabbit EFD

Dawnzera

donidalorsen · Prekallikrein / KLKB1 (ASO)
Mouse (CD-1) and cynomolgus monkey

Defitelio

defibrotide · Fragmented DNA oligonucleotides
Rat and dog

Exondys 51

eteplirsen · DMD exon 51 (PMO)
Cynomolgus monkey and juvenile rat (eteplirsen); mdx/C57BL mouse incl. mouse surrogate

Givlaari

givosiran · ALAS1 (siRNA)
Rat and cynomolgus monkey (both pharmacologically active); rabbit inactive (EFD only)

Hibsago

bepirovirsen · HBV RNA (ASO)
Mouse and rabbit in labeled studies (carcinogenicity, reproduction); general-toxicity species not stated

Izervay

avacincaptad pegol · C5 (aptamer)
Rabbit and dog (IVT ocular studies); rat and cynomolgus monkey (7-day IV); monkey the only pharmacologically relevant species

Kynamro

mipomersen · APOB (ASO)
Mouse, rat and cynomolgus monkey (clinical ASO plus rodent surrogates)

Leqvio

inclisiran · PCSK9 (siRNA)
Rat and cynomolgus monkey (both pharmacologically active); rabbit for EFD

Macugen

pegaptanib · VEGF-165 (aptamer)
Rabbit and dog (pivotal IVT); rat IV for systemic; supportive monkey, mouse

Onpattro

patisiran · TTR (siRNA)
Rat and cynomolgus monkey (monkey pharmacologically active; rat off-target/LNP)

Oxlumo

lumasiran · HAO1 (siRNA)
Rat and cynomolgus monkey (both pharmacologically relevant); rabbit for EFD

Qalsody

tofersen · SOD1 (ASO)
Cynomolgus monkey (IT, relevant species), CD-1 mouse (SC) and rat single-dose IT

Qfitlia

fitusiran · Antithrombin / SERPINC1 (siRNA)
Healthy rat and cynomolgus monkey (GLP); hemophilia A mouse, hemophilia A dog and induced-HA monkey models

Redemplo

plozasiran · APOC3 (siRNA)
Rat (off-target toxicity) and cynomolgus monkey (pharmacologically relevant)

Rivfloza

nedosiran · LDHA (siRNA)
Cynomolgus monkey (relevant) plus mouse (nedosiran inactive; off-target assessment)

Spinraza

nusinersen · SMN2 (ASO)
Juvenile cynomolgus monkey (IT) and CD-1 mouse (SC, systemic effects)

Tegsedi

inotersen · TTR (ASO)
Mouse, rat and cynomolgus monkey; monkey the only pharmacologically relevant species

Tryngolza

olezarsen · APOC3 (ASO)
Mouse (with surrogate) and cynomolgus monkey

Viltepso

viltolarsen · DMD exon 53 (PMO)
Male CD-1 mouse and male cynomolgus monkey (plus juvenile male mouse)

Vitravene

fomivirsen · CMV IE2 mRNA (ASO)
Rabbit and monkey

Vyondys 53

golodirsen · DMD exon 53 (PMO)
Mouse, cynomolgus monkey (adult males) and juvenile rat

Wainua

eplontersen · TTR (ASO)
Mouse and cynomolgus monkey (monkey the pharmacologically relevant species)

Waylivra

volanesorsen · APOC3 (ASO)
Mouse, rat and cynomolgus monkey (rabbit for embryo-fetal); monkey most relevant

Zanvastro

zilganersen · GFAP (ASO)
Mouse (SC and ICV, juvenile) and juvenile monkey (intrathecal); mouse surrogate ASO arm

Summary across all 27 oligonucleotides →